{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:06:27Z","timestamp":1786118787282,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-026-05279-x","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:42:39Z","timestamp":1786034559000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transurethral prostate resection with high-intensity focused ultrasound achieves a superior functional outcome in prostate cancer patients"],"prefix":"10.1007","author":[{"given":"Tsu-Chen","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Chieh","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Lin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-Cheng","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Hung","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Hung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Keng","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"See-Tong","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Te","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Jie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"issue":"6","key":"5279_CR1","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.euo.2021.09.006","volume":"4","author":"G Gandaglia","year":"2021","unstructured":"Gandaglia G, Leni R, Bray F et al (2021) Epidemiology and prevention of prostate cancer. Eur Urol Oncol 4(6):877\u2013892","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"5279_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.urolonc.2024.06.003","volume":"43","author":"VM Sundaresan","year":"2025","unstructured":"Sundaresan VM, Smani S, Rajwa P et al (2025) Prostate-specific antigen screening for prostate cancer: diagnostic performance, clinical thresholds, and strategies for refinement. Urol Oncol 43(1):41\u201348","journal-title":"Urol Oncol"},{"key":"5279_CR3","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.amsu.2020.05.029","volume":"56","author":"F Ziglioli","year":"2020","unstructured":"Ziglioli F, Baciarello M, Maspero G et al (2020) Oncologic outcome, side effects and comorbidity of high-intensity focused ultrasound (HIFU) for localized prostate cancer. A review. Ann Med Surg (Lond) 56:110\u2013115","journal-title":"Ann Med Surg (Lond)"},{"issue":"1","key":"5279_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.eururo.2016.08.044","volume":"71","author":"M Valerio","year":"2017","unstructured":"Valerio M, Cerantola Y, Eggener SE et al (2017) New and established technology in focal ablation of the prostate: a systematic review. Eur Urol 71(1):17\u201334","journal-title":"Eur Urol"},{"issue":"S1","key":"5279_CR5","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1089\/end.2016.0548","volume":"31","author":"CG Chaussy","year":"2017","unstructured":"Chaussy CG, Th\u00fcroff S (2017) High-intensity focused ultrasound for the treatment of prostate cancer: a review. J Endourol 31(S1):S30\u2013S37","journal-title":"J Endourol"},{"issue":"4","key":"5279_CR6","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.eururo.2022.01.005","volume":"81","author":"D Reddy","year":"2022","unstructured":"Reddy D, Peters M, Shah TT et al (2022) Cancer control outcomes following focal therapy using high-intensity focused ultrasound in 1379 men with nonmetastatic prostate cancer: a multi-institute 15-year experience. Eur Urol 81(4):407\u2013413","journal-title":"Eur Urol"},{"issue":"2","key":"5279_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.prnil.2019.12.002","volume":"8","author":"PL Royce","year":"2020","unstructured":"Royce PL, Ooi JJY, Sothilingam S, Yao HH (2020) Survival and quality of life outcomes of high-intensity focused ultrasound treatment of localized prostate cancer. Prostate Int 8(2):85\u201390","journal-title":"Prostate Int"},{"key":"5279_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-024-00911-2","author":"KJ Tay","year":"2024","unstructured":"Tay KJ, Fong KY, Stabile A et al (2024) Established focal therapy-HIFU, IRE, or cryotherapy-where are we now?-a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. https:\/\/doi.org\/10.1038\/s41391-024-00911-2","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"15","key":"5279_CR9","first-page":"3346","volume":"55","author":"S Madersbacher","year":"1995","unstructured":"Madersbacher S, Pedevilla M, Vingers L, Susani M, Marberger M (1995) Effect of high-intensity focused ultrasound on human prostate cancer in vivo. Cancer Res 55(15):3346\u20133351","journal-title":"Cancer Res"},{"key":"5279_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13225696","author":"D Cranston","year":"2021","unstructured":"Cranston D, Leslie T, Ter Haar G (2021) A review of high-intensity focused ultrasound in urology. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13225696","journal-title":"Cancers (Basel)"},{"issue":"4","key":"5279_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2024.102101","volume":"22","author":"ZLP Guang","year":"2024","unstructured":"Guang ZLP, Kristensen G, R\u00f8der A, Brasso K (2024) Oncological and functional outcomes of whole-gland hifu as the primary treatment for localized prostate cancer: a systematic review. Clin Genitourin Cancer 22(4):102101","journal-title":"Clin Genitourin Cancer"},{"key":"5279_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2024.11.005","author":"B Nahar","year":"2024","unstructured":"Nahar B, Ajami T, Williams A et al (2024) Survival outcomes and recurrence patterns following focal high-intensity focused ultrasound treatment for localized prostate cancer: insights on patient selection and lessons learned. Eur Urol Focus. https:\/\/doi.org\/10.1016\/j.euf.2024.11.005","journal-title":"Eur Urol Focus"},{"key":"5279_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2024.11.006","author":"G Ploussard","year":"2024","unstructured":"Ploussard G, Coloby P, Chevallier T et al (2024) Whole-gland or subtotal high-intensity focused ultrasound versus radical prostatectomy: The Prospective, noninferiority, nonrandomized HIFI Trial. Eur Urol. https:\/\/doi.org\/10.1016\/j.eururo.2024.11.006","journal-title":"Eur Urol"},{"issue":"4","key":"5279_CR14","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1097\/JU.0000000000001126","volume":"204","author":"AL Abreu","year":"2020","unstructured":"Abreu AL, Peretsman S, Iwata A et al (2020) High intensity focused ultrasound hemigland ablation for prostate cancer: initial outcomes of a United States series. J Urol 204(4):741\u2013747","journal-title":"J Urol"},{"issue":"3","key":"5279_CR15","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/s41391-024-00921-0","volume":"28","author":"S Shoji","year":"2025","unstructured":"Shoji S, Naruse J, Ohno S et al (2025) Focal therapy using high-intensity focused ultrasound with intraoperative prostate compression for patients with localized prostate cancer: a multi-center prospective study with 7 year experience. Prostate Cancer Prostatic Dis 28(3):782\u2013788","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"5279_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/960835","author":"U Maestroni","year":"2012","unstructured":"Maestroni U, Dinale F, Minari R, Salsi P, Ziglioli F (2012) High-intensity focused ultrasound for prostate cancer: long-term followup and complications rate. Adv Urol. https:\/\/doi.org\/10.1155\/2012\/960835","journal-title":"Adv Urol"},{"key":"5279_CR17","first-page":"100854","volume":"49","author":"T Bourgarit","year":"2024","unstructured":"Bourgarit T, Larose C, Dagry A et al (2024) Complications leading to hospitalisation 12 months after brachytherapy or high-intensity focused ultrasound for localized prostate cancer: French national from the PMSI-MCO data, 2019 and 2020. Clin Transl Radiat Oncol 49:100854","journal-title":"Clin Transl Radiat Oncol"},{"issue":"2","key":"5279_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1590\/s1677-5538.ibju.2021.0091","volume":"48","author":"A Bakavicius","year":"2022","unstructured":"Bakavicius A, Marra G, Macek P et al (2022) Available evidence on HIFU for focal treatment of prostate cancer: a systematic review. Int Braz J Urol 48(2):263\u2013274","journal-title":"Int Braz J Urol"},{"issue":"5","key":"5279_CR19","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.urology.2007.12.076","volume":"71","author":"A Blana","year":"2008","unstructured":"Blana A, Hierl J, Rogenhofer S et al (2008) Factors predicting for formation of bladder outlet obstruction after high-intensity focused ultrasound in treatment of localized prostate cancer. Urology 71(5):863\u2013867","journal-title":"Urology"},{"key":"5279_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.988490","volume":"12","author":"Y Pan","year":"2022","unstructured":"Pan Y, Wang S, Liu L, Liu X (2022) Whole-gland high-intensity focused ultrasound ablation and transurethral resection of the prostate in the patients with prostate cancer: a systematic review and meta-analysis. Front Oncol 12:988490","journal-title":"Front Oncol"},{"issue":"1","key":"5279_CR21","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1016\/j.clgc.2021.09.003","volume":"20","author":"SS Byun","year":"2022","unstructured":"Byun SS, Jin N, Lee H (2022) High intensity focused ultrasound ablation for prostate cancer: whole versus partial gland ablation. Clin Genitourin Cancer 20(1):e39\u2013e44","journal-title":"Clin Genitourin Cancer"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05279-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05279-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05279-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:42:40Z","timestamp":1786034560000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-026-05279-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":21,"alternative-id":["5279"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05279-x","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"assertion":[{"value":"1 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethical Committee of Chang Gung Medical Foundation (IRB approval number: 202500341B0) and was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethial approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}